pros and cons of glp 1 drugs 🎉A new approach to weight loss! 🎉 GLP-1 medications are changing the landscape weight management. Join us for FREE classes to learn more about these medicines. ➡️This week's class: ⏰SATURDAY MAR Who should take them? Pros

PMID 23524641

Brand-name advantages FDA-approved medications like Wegovy and Zepbound undergo extensive testing for purity, potency, sterility, and stability

As the presented experiments do not report absolute changes in alcohol drinking after GLP-1R agonist treatment, the effectiveness of the different agonists cannot be compared

Of the over 17,000 patients enrolled in the SELECT trial, about 25% had heart failure, of which about one-third had HFrEF

forecasts that the general obesity drug market could reach $200 billion by 2030 as global adoption expands and indications stretch beyond diabetes and weight management

Zvenyach also stressed how its unclear whether patients will need to regularly take these drugs for the rest of their lives a key cost concern raised by public officials